Dual-Action Oral Antineoplastic Regimens Extending Survival in Advanced Refractory Colorectal Cancer
Delivering effective oral chemotherapy regimens for patients with pre-treated metastatic gastrointestinal malignancies is a critical priority in late-stage clinical oncology. Detailed analysis within the Trifluridine Tipiracil Tablet Market report indicates how the fixed-dose combination of trifluridine (a nucleoside metabolic inhibitor) and tipiracil (a thymidine phosphorylase inhibitor)...